Posts In: COVID-19 Pandemic

View Post

The Dividend Aristocrats & The COVID Cutters

While dozens of S&P 500 companies have suspended or lowered their dividend payments during the pandemic, the S&P 500 Dividend…Read More

View Post

The Big Names, Smaller Newcomers, And Emerging Market Players In The Race For A COVID Cure

From prominent names such as Moderna to smaller newcomers such as Tyme Technologies to emerging market players such as Indian…Read More

View Post

The Recent “Tidal Wave” Of Vaccine News Is An Alert For Investors

A “tidal wave” of COVID-19 vaccine news has hit the market in recent days – and is likely a prelude…Read More

View Post

3 Lesser-Known Stocks To Profit From Certain Healthcare Growth

While many medical appointments and procedures have been put off during the COVID-19 crisis, the healthcare sector is destined to…Read More

View Post

What’s Really Driving Stock Returns (And Signaling More Upside Ahead)?

Despite the narrative to the contrary, higher levels of activity by individual investors during the pandemic has not been boosting…Read More

View Post

A Wrinkle In Reopening Creates A New Puzzle For Investors

With coronavirus cases surging in many parts of the country, the reopening process has halted in several states – and…Read More

View Post

The Dividend Danger Zone

There are solid dividend-paying stocks out there, but these seven dividend stocks may not be among them. In fact, amid…Read More

View Post

AbbVie’s 3 For 3

Drugmaker AbbVie scored three big wins in recent days – one in the courtroom, one in a clinical study, and…Read More

View Post

Snapping Up Small-Caps

As coronavirus lockdown restrictions have lifted, small-cap stocks have surged – and some hedge funds are favoring small-caps amid early…Read More

View Post

COVID-19’s Potentially Long-Lasting Impact On ESG Investing

While it was already attracting an increasing amount of investor attention – and money – before the coronavirus outbreak, the…Read More